Immunotherapies
have evolved
Harnessing more of the immune system for better cancer outcomes
Latest News
Retweet on Twitter oNKo-innate Retweeted
Nicholas Huntington @dr_nick_bikes ·
29 Nov

We hosted @jonatcoquet from KI today at @oNKo_innate and heard some fascinating insights into novel roles for Th2 cells in infection and cancer. Thanks for the stimulating visit Jonno 🙏

Reply on Twitter 1597407124812107776 Retweet on Twitter 1597407124812107776 2 Like on Twitter 1597407124812107776 33 Twitter 1597407124812107776
Retweet on Twitter oNKo-innate Retweeted
jonatcoquet @jonatcoquet ·
29 Nov

@Dr_Nick_Bikes @oNKo_innate Pleased to come and talk at onko! It was a great environment to speak in. Thanks for entertaining my random thoughts on Cd4s and cancer

Reply on Twitter 1597413915411247104 Retweet on Twitter 1597413915411247104 1 Like on Twitter 1597413915411247104 6 Twitter 1597413915411247104
oNKo-innate @onko_innate ·
25 Nov

Calling all post-doc level scientists wanting a career in industry with some of the best in immuno-oncology research:
http://careersaustralia.monash.edu/cw/en/job/644196/senior-research-scientist
We can't wait to meet you --> applications close December 11 🙏

Reply on Twitter 1596018905616900096 Retweet on Twitter 1596018905616900096 13 Like on Twitter 1596018905616900096 20 Twitter 1596018905616900096
Load More...
 
Press Release
oNKo-innate named Australian Emerging Company of the Year
Press Release
Monash University and oNKo-innate Announce Research Partnership
Press Release
Gilead, Kite and oNKo-innate announce research collaboration
Discover oNKo-innate
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.
Learn more
OUR APPROACH
Using powerful genomic approaches, we screen primary immune cells and cancer cells to understand their interaction within a tumor.
Learn more
lab1-webRes
o o
o
THE TEAM
We are driven by the challenge of engaging the immune system to fight cancer, and focused on delivering the first truly effective NK cell immunotherapies.
Find out who we are